Twist Bioscience Corp (FRA:0ME)
€ 39.22 -1.36 (-3.35%) Market Cap: 2.23 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 4.90 GF Score: 83/100

Q3 2019 Twist Bioscience Corp Earnings Call Transcript

Aug 01, 2019 / 08:30PM GMT
Release Date Price: €29.95 (+0.23%)
Operator

Good day, ladies and gentlemen and welcome to the Twist Bioscience Fiscal 2019 Third Quarter Financial Results Conference Call.

At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. (Operator Instructions) As a reminder, today's conference is being recorded.

I would like to introduce your host of this conference call, Mr. Jim Thorburn, Chief Financial Officer. You may begin.

Jim Thorburn
Twist Bioscience Corporation - CFO

All right. Thank you, Kevin. Good afternoon, everyone, and thank you for joining us today for Twist Bioscience conference call to review our fiscal 2019 third quarter financial results and our business progress. Please review the press release we issued earlier today which is available at our website, www.twistbioscience.com.

With me on today's call is Dr. Emily Leproust, CEO and Co-Founder of Twist. Emily will begin with a review of our overall

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot